Nebraska clinical trial shows cannabidiol benefits
A lot of patients suffering from epilepsy during a clinical trial were treated with cannabis oil showed improvement in their seizures.
The trial was conducted at the University of Nebraska Medical Center in 2015 which highlighting twenty-three participated patients treated with cannabidiol (CBD oil) gained improvement. The patients who participated in this two-year trial were reportedly having epilepsy that regular drugs couldn’t cure.
UNMC's associate Vice Chancellor, Christopher Kratochvil, said the patients with the two most specific forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome experienced a remarkable improvement.
The Epidiolex oral solution was the ideal drug used in this study that was approved by FDA in June.